IN2013MU00646A - - Google Patents
Download PDFInfo
- Publication number
- IN2013MU00646A IN2013MU00646A IN646MU2013A IN2013MU00646A IN 2013MU00646 A IN2013MU00646 A IN 2013MU00646A IN 646MU2013 A IN646MU2013 A IN 646MU2013A IN 2013MU00646 A IN2013MU00646 A IN 2013MU00646A
- Authority
- IN
- India
- Prior art keywords
- preparation
- present
- crystalline form
- provides novel
- endoxifen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
- C07C217/14—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
- C07C217/18—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IN2014/000136 WO2014141292A2 (fr) | 2013-03-04 | 2014-03-03 | Polymorphe de citrate d'endoxifène et son procédé de préparation |
IN646MU2013 IN2013MU00646A (fr) | 2013-03-04 | 2014-03-03 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN646MU2013 IN2013MU00646A (fr) | 2013-03-04 | 2014-03-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2013MU00646A true IN2013MU00646A (fr) | 2015-06-26 |
Family
ID=51538243
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN646MU2013 IN2013MU00646A (fr) | 2013-03-04 | 2014-03-03 |
Country Status (2)
Country | Link |
---|---|
IN (1) | IN2013MU00646A (fr) |
WO (1) | WO2014141292A2 (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2018521988A (ja) | 2015-06-16 | 2018-08-09 | ジエンス ヘンルイ メデイシンカンパニー リミテッドJiangsu Hengrui Medicine Co.,Ltd. | ピペリジン誘導体およびその製造方法および医薬用途 |
CN107428721B (zh) | 2015-12-22 | 2020-07-28 | 江苏恒瑞医药股份有限公司 | 苯并哌啶类衍生物、其制备方法及其在医药上的应用 |
AU2018329202B2 (en) * | 2017-09-11 | 2022-10-27 | Atossa Therapeutics, Inc. | Methods for making and using endoxifen |
ES2912740T3 (es) | 2017-11-14 | 2022-05-27 | Kind Pharmaceutical | Compuesto heterocíclico y aplicación del mismo en medicina |
CA3164166A1 (fr) | 2020-01-10 | 2021-07-15 | Jiangsu Hengrui Medicine Co., Ltd. | Derive tetrahydroisoquinoline tricyclique, son procede de preparation et son application en medecine |
CA3177266A1 (fr) * | 2020-04-10 | 2021-10-14 | Jina Pharmaceuticals, Inc. | Endoxifene pour le traitement d'un trouble bipolaire i |
CN115484941A (zh) | 2020-04-10 | 2022-12-16 | 金纳药业公司 | 因多昔芬用于治疗双相i型障碍 |
KR20240035515A (ko) | 2021-07-09 | 2024-03-15 | 지앙수 헨그루이 파마슈티컬스 컴퍼니 리미티드 | 삼중 고리 테트라하이드로 이소퀴놀린계 유도체의 염의 형태 |
TW202340135A (zh) | 2022-01-12 | 2023-10-16 | 美商阿托薩醫療公司 | (z)—因多昔芬之組合物及其富集方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW593256B (en) * | 1999-11-16 | 2004-06-21 | Hormos Medical Oy Ltd | Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
US20090291134A1 (en) * | 2006-11-21 | 2009-11-26 | Jina Pharmaceuticals, Inc. | Endoxifen methods and compositions in the treatment of psychiatric and neurodegenerative diseases |
WO2009120999A2 (fr) * | 2008-03-28 | 2009-10-01 | Olema Pharmaceuticals, Inc. | Utilisation d’un promédicament d’endoxifène dans le traitement du cancer de la poitrine |
KR101308258B1 (ko) * | 2010-10-15 | 2013-09-13 | 씨제이제일제당 (주) | 엔독시펜의 신규한 제조 방법 |
-
2014
- 2014-03-03 IN IN646MU2013 patent/IN2013MU00646A/en unknown
- 2014-03-03 WO PCT/IN2014/000136 patent/WO2014141292A2/fr active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2014141292A2 (fr) | 2014-09-18 |
WO2014141292A3 (fr) | 2014-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2013MU00646A (fr) | ||
IN2014CH00247A (fr) | ||
MX370649B (es) | Proceso para la preparacion de teneligliptina. | |
IN2013MU00848A (fr) | ||
IL249872A0 (en) | Amorphous form of eliglostat hemetrate, preparations containing it and methods for its preparation | |
IL245474B (en) | Process for preparing 5-fluoro-1h-pyrazoles | |
IN2014MU00455A (fr) | ||
IL245476A0 (en) | Process for preparing 5-fluoro-1h-pyrazoles | |
IN2013MU03070A (fr) | ||
EP3016935A4 (fr) | Procédé pour la préparation d'intermédiaire de dolutégravir | |
MA40312A (fr) | Composition pharmaceutique orale d'isotrétinoïne | |
IN2013MU01113A (fr) | ||
PL2964607T3 (pl) | Sposób wytwarzania halogeno-n,n-dimetylobenzyloamin | |
IL229326A (en) | Process for making n-iodine-affluent | |
MX2017001331A (es) | Composicion farmaceutica oral de isotretinoina. | |
MX2016016398A (es) | Preparacion de piperidin-4-carbotioamida. | |
MX2015011881A (es) | Proceso para la preparacion de 3,7-dimetilnonan-1-ol. | |
WO2014170909A3 (fr) | Procédé de préparation de pomalidomide | |
IN2013MU02528A (fr) | ||
MX2016005146A (es) | Metodo para producir halocetonas. | |
IN2014CH01391A (fr) | ||
IN2013MU03768A (fr) | ||
IN2013MU01501A (fr) | ||
IN2013CH05395A (fr) | ||
IL246188B (en) | A process for the preparation of tiacomycin |